H. Guchelaar
发表
Jun S. Liu,
Michael H. Guo,
P. Visscher,
2013
.
H. Guchelaar,
Mariëlle J Nagtegaal,
J. Swen,
2014,
Pharmacogenomics.
H. Guchelaar,
J. Swen,
J. Swen,
2011,
Clinical pharmacology and therapeutics.
Magnus Rattray,
Thomas Lengauer,
Haralampos Karanikas,
2016,
Genome Medicine.
H. Guchelaar,
H. Gelderblom,
I. de Hingh,
2020,
Frontiers in Pharmacology.
H. Guchelaar,
O. Ackaert,
F. Smiers,
2014,
Therapeutic drug monitoring.
H. Rosing,
J. Beijnen,
H. Guchelaar,
2013,
Clinical therapeutics.
M. Whirl‐Carrillo,
K. Sangkuhl,
T. Klein,
2018,
Clinical pharmacology and therapeutics.
R. Vossen,
S. Anvar,
P. Neven,
2020,
bioRxiv.
A. V. van Kuilenburg,
H. Rosing,
J. Beijnen,
2018,
Annals of oncology : official journal of the European Society for Medical Oncology.
H. Guchelaar,
J. Swen,
C. H. van der Wouden,
2020,
Advances in Molecular Pathology.
M. Ingelman-Sundberg,
V. Lauschke,
H. Guchelaar,
2019,
Clinical pharmacology and therapeutics.
M. Relling,
M. Whirl‐Carrillo,
T. Klein,
2018,
Clinical pharmacology and therapeutics.
A. V. van Kuilenburg,
J. Schellens,
H. Rosing,
2018,
The Lancet. Oncology.
H. Boezen,
H. Hoekstra,
H. Guchelaar,
2010,
Cancer.
R. Vossen,
S. Anvar,
J. D. den Dunnen,
2017,
Human mutation.
H. Guchelaar,
Jos M. van den Broek,
M. V. van Beusekom,
2018,
Drug discovery today.
R. Herings,
H. Guchelaar,
T. Nijsten,
2009,
Annals of oncology : official journal of the European Society for Medical Oncology.
Henk-Jan Guchelaar,
D. Richel,
H. Guchelaar,
2004,
Cancer treatment reviews.
H. Guchelaar,
O. Klungel,
J. Swen,
2008,
Clinical pharmacology and therapeutics.
H. Guchelaar,
J. Swen,
M. Crone,
2020,
Journal of clinical medicine.
H. Guchelaar,
J. Swen,
C. H. van der Wouden,
2019,
Genes.
H. Guchelaar,
R. V. van Schaik,
J. Swen,
2019,
European Journal of Human Genetics.
H. Guchelaar,
J. Swen,
J. J. Swen,
2019,
BMC Medicine.
H. Guchelaar,
J. Swen,
P. C. Bank,
2018,
Advances in pharmacology.
H. Guchelaar,
2018,
European Journal of Human Genetics.
M. Samwald,
H. Guchelaar,
M. Schwab,
2016,
European Journal of Human Genetics.
H. Guchelaar,
J. Swen,
T. van der Straaten,
2015,
Pharmacogenomics.
H. Guchelaar,
H. Gelderblom,
M. Koopman,
2013,
Pharmacogenomics.
H. Guchelaar,
J. Swen,
2011,
The Annals of pharmacotherapy.
T. Egberts,
H. Guchelaar,
M. Arbouw,
2010,
Pharmacogenomics.
G. Meijer,
C. Punt,
H. Guchelaar,
2009
.
Henk-Jan Guchelaar,
Jesse J Swen,
W. Assendelft,
2007,
PLoS medicine.
H. Guchelaar,
T. Huizinga,
T. van der Straaten,
2009,
Drug discovery today.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2010,
European journal of cancer.
S. H. van der Burg,
E. Jordanova,
H. Morreau,
2011,
Clinical Cancer Research.
H. Guchelaar,
H. Elzevier,
M. Teichert,
2020,
Family practice.
P. Hudson,
H. Guchelaar,
2003,
Pharmacy World and Science.
Judith A M Wessels,
Henk-Jan Guchelaar,
B. Dijkmans,
2006,
Arthritis and rheumatism.
B. Ploeger,
M. Danhof,
H. Guchelaar,
2010,
European Journal of Clinical Pharmacology.
B. Ploeger,
M. Danhof,
H. Guchelaar,
2009,
Therapeutic drug monitoring.
H. Guchelaar,
H. Gelderblom,
J. Hartigh,
2013,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
J. D. de Fijter,
H. Guchelaar,
R. R. Press,
2010,
Current pharmaceutical design.
H. Guchelaar,
R. V. van Schaik,
H. V. van Laarhoven,
2015,
Therapeutic drug monitoring.
H. Guchelaar,
J. Hartigh,
R. R. Press,
2012,
Clinical Pharmacokinetics.
B. Ploeger,
H. Guchelaar,
H. Gelderblom,
2010,
Cancer Chemotherapy and Pharmacology.
P. V. D. van der Boog,
J. D. de Fijter,
H. Guchelaar,
2020,
Clinical Pharmacokinetics.
H. Guchelaar,
N. Mulder,
E. de Vries,
1994,
Clinical oncology (Royal College of Radiologists (Great Britain)).
H. Guchelaar,
M. Lowdell,
C. Herberts,
2016,
Drug discovery today.
H. Guchelaar,
J. Swen,
M. Fiocco,
2017,
Acta oncologica.
J. Kremer,
H. Guchelaar,
T. Huizinga,
2012,
Pharmacogenetics and genomics.
Henk-Jan Guchelaar,
Loraine Lie-A-Huen,
Susanne M. Smorenburg,
2009,
Drug safety.
P. Hudson,
H. Guchelaar,
M. D. Kalmeijer,
2005,
Drugs.
Henk-Jan Guchelaar,
A. V. van Kuilenburg,
D. Richel,
2007,
European journal of cancer.
J. Maring,
H. Guchelaar,
H. Gelderblom,
2016
.
J. Maring,
H. Guchelaar,
H. Gelderblom,
2015,
Cancer Chemotherapy and Pharmacology.
T. Egberts,
H. Guchelaar,
K. Movig,
2007,
European Journal of Clinical Pharmacology.
H. Guchelaar,
N. Ouwerkerk,
D. Kweekel,
2021,
International journal of pharmaceutics.
H. Guchelaar,
T. Huizinga,
W. M. Kooloos,
2009,
Rheumatology.
H. Guchelaar,
K. Olie,
J. Koppe,
2008,
Chemosphere.
H. Guchelaar,
H. Gelderblom,
A. Sparreboom,
2013,
Cancer Chemotherapy and Pharmacology.
H. Guchelaar,
T. Nijsten,
E. Koomen,
2010
.
H. Guchelaar,
S. D. de Wilde,
M. Zandvliet,
2017,
Cytotherapy.
H. Guchelaar,
J. Zwaveling,
K. Gombert-Handoko,
2020,
Clinical pharmacology and therapeutics.
H. Guchelaar,
H. Gelderblom,
K. Schimmel,
2007
.
G. Peters,
H. Guchelaar,
V. van der Noort,
2017,
Pharmacological research.
H. Guchelaar,
H. Gelderblom,
F. Opdam,
2012,
Cancer treatment reviews.
H. Guchelaar,
J. Sastre Toraño,
1998,
Journal of chromatography. B, Biomedical sciences and applications.
R. Herings,
H. Guchelaar,
T. Nijsten,
2007,
European journal of cancer.
H. Putter,
E. Berns,
C. Seynaeve,
2013,
Breast Cancer Research and Treatment.
P. Hudson,
H. Guchelaar,
M. D. Kalmeijer,
2012,
Drugs.
Y. Okada,
A. Barton,
S. Raychaudhuri,
2019,
Annals of the rheumatic diseases.
J. Houwing-Duistermaat,
N. Sattar,
J. Deelen,
2013,
PloS one.
R. Meyboom,
E. V. van Puijenbroek,
H. Guchelaar,
2004,
Pharmacy World and Science.
H. Guchelaar,
S. Böhringer,
Kirsten J.M. Schimmel,
2019,
Scientific Reports.
H. Guchelaar,
J. Swen,
C. H. van der Wouden,
2017,
Pharmacogenomics.
H. Guchelaar,
A. Pérez‐Pitarch,
D. Moes,
2016,
Cancer Chemotherapy and Pharmacology.
P. Neven,
D. Lambrechts,
H. Guchelaar,
2020,
Cancer Chemotherapy and Pharmacology.
G. Demetri,
H. Guchelaar,
H. Gelderblom,
2014,
BMC Cancer.
H. Guchelaar,
J. Swen,
M. Manson,
2020,
Journal of clinical medicine.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2016,
Expert review of molecular diagnostics.
H. Guchelaar,
K. Koudijs,
A. G. T. Terwisscha van Scheltinga,
2019,
Cancer journal.
H. Pijl,
H. Guchelaar,
S. Böhringer,
2016,
Breast Cancer Research.
J. Schellens,
H. Guchelaar,
H. Gelderblom,
2018,
European journal of cancer.
A. V. van Kuilenburg,
J. Schellens,
H. Rosing,
2019,
European journal of cancer.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2009,
European journal of cancer.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2009
.
H. Guchelaar,
E. de Vries,
D. Daryanani,
2000,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
D. Richel,
H. Guchelaar,
H. Guchelaar,
1996,
Cancer treatment reviews.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2014,
PloS one.
H. Guchelaar,
S. D. de Wilde,
M. Zandvliet,
2016,
Cytotherapy.
H. Guchelaar,
H. Gelderblom,
J. den Hartigh,
2015,
Therapeutic drug monitoring.
H. Guchelaar,
J. Swen,
2012,
Pharmacogenomics.
R. Herings,
H. Guchelaar,
T. Nijsten,
2010
.
R. Herings,
H. Guchelaar,
T. Nijsten,
2009,
The Journal of investigative dermatology.
R. Herings,
H. Guchelaar,
T. Nijsten,
2009,
Melanoma research.
H. Putter,
E. Berns,
C. Seynaeve,
2013,
Breast Cancer Research and Treatment.
H. Guchelaar,
J. Swen,
T. van der Straaten,
2012,
Pharmacogenomics.
C. Allaart,
H. Guchelaar,
J. Swen,
2019,
Pharmacogenomics.
H. Guchelaar,
T. Huizinga,
J. Swen,
2015,
Pharmacogenomics.
J. Stingl,
H. Guchelaar,
G. Patrinos,
2017,
European Journal of Clinical Pharmacology.
J. Nortier,
H. Guchelaar,
H. Gelderblom,
2009,
Investigational New Drugs.
H. Guchelaar,
E. de Vries,
J. Oosterhuis,
1992,
British Journal of Cancer.
M. Schilham,
H. Guchelaar,
M. Kester,
2010,
Haematologica.
E. Giovannetti,
G. Peters,
G. Giaccone,
2011,
Pharmacogenomics.
H. Guchelaar,
R. Wolterbeek,
H. Gelderblom,
2015,
Therapeutic drug monitoring.
H. Guchelaar,
T. van der Straaten,
R. Baak-Pablo,
2013,
Pharmacogenetics and genomics.
H. Guchelaar,
D. Bosch,
P. Merkus,
2003,
Neurology.
H. Guchelaar,
J. Swen,
T. van Gelder,
2021,
medRxiv.
M. Ingelman-Sundberg,
V. Lauschke,
H. Guchelaar,
2020,
Basic & clinical pharmacology & toxicology.
B. Rini,
H. Guchelaar,
H. Gelderblom,
2016,
Oncotarget.
H. Guchelaar,
2004
.
H. Guchelaar,
I. Vermes,
C. Haanen,
1997,
Pharmacy World and Science.
P. V. D. van der Boog,
J. D. de Fijter,
H. Guchelaar,
2021,
Drug discovery today.
H. Guchelaar,
H. Gelderblom,
J. Hartigh,
2015
.
T. Egberts,
H. Guchelaar,
K. Movig,
2008,
European Journal of Clinical Pharmacology.
T. Egberts,
H. Guchelaar,
K. Movig,
2009
.
H. Guchelaar,
N. Mulder,
E. de Vries,
1993,
International journal of cancer.
J. Nortier,
H. Guchelaar,
H. Gelderblom,
2011,
Japanese journal of clinical oncology.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2020,
Clinical Pharmacokinetics.
B. Ploeger,
J. Romijn,
H. Guchelaar,
2011,
European journal of endocrinology.
H. Guchelaar,
H. Gelderblom,
A. Modak,
2015,
Journal of breath research.
R. Brink,
D. Richel,
H. Guchelaar,
2007
.
J. Schellens,
H. Rosing,
J. Beijnen,
2018,
British journal of clinical pharmacology.
A. Verbeek,
D. D. de Jong,
M. Coenen,
2017,
Alimentary pharmacology & therapeutics.
M. Relling,
T. Klein,
T. Klein,
2011,
Clinical pharmacology and therapeutics.
H. Putter,
J. Nortier,
H. Guchelaar,
2012,
International Journal of Gynecologic Cancer.
H. Putter,
J. Nortier,
H. Guchelaar,
2011,
Japanese journal of clinical oncology.
J. Nortier,
H. Guchelaar,
M. Karlsson,
2007,
Clinical Cancer Research.
P. Neven,
H. Guchelaar,
S. Böhringer,
2019,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2018,
Breast Cancer Research and Treatment.
B. van Calster,
P. Neven,
S. Van Huffel,
2018,
Clinical Cancer Research.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2017,
European Journal of Clinical Pharmacology.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2017,
Pharmacogenomics.
A. V. van Kuilenburg,
H. Guchelaar,
K. D. de Bruin,
2005,
Archives of Toxicology.
H. Guchelaar,
H. Gelderblom,
Lieke Henriette Tanja,
2009,
Best practice & research. Clinical gastroenterology.
H. Guchelaar,
J. Lindemans,
R. Jonge,
2009
.
H. Guchelaar,
M. D. Kalmeijer,
H.-J. Guchelaar,
2003,
Pharmacy World and Science.
T. van der Poll,
H. Guchelaar,
M. Schultz,
2001,
Fundamental & clinical pharmacology.
H. Guchelaar,
C. D. Borgie,
G. Frijstein,
2002
.
A. Verbeek,
M. Bouvy,
D. D. de Jong,
2018,
European journal of gastroenterology & hepatology.
Henk-Jan Guchelaar,
A. Egberts,
D. Richel,
2004,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
H. Guchelaar,
L. Lie-A-Huen,
G. Groeneveld,
2008,
Clinical pharmacology and therapeutics.
L. H. van den Berg,
H. Guchelaar,
S. Kalmijn,
2005,
British journal of clinical pharmacology.
L. H. van den Berg,
J. Veldink,
H. Guchelaar,
2003,
Neurology.
H. Guchelaar,
T. Huizinga,
R. Jonge,
2007
.
J. Nortier,
H. Guchelaar,
H. Gelderblom,
2009
.
J. Maring,
H. Guchelaar,
H. Gelderblom,
2014,
The Pharmacogenomics Journal.
A. V. van Kuilenburg,
J. Schellens,
H. Guchelaar,
2017,
JCO precision oncology.
EU decision-making for marketing authorization of advanced therapy medicinal products: a case study.
J. Hoekman,
H. Leufkens,
H. Guchelaar,
2018,
Drug discovery today.
L. H. van den Berg,
H. Guchelaar,
J. S. Toraño,
2004,
Biomedical chromatography : BMC.
H. Putter,
A. Egberts,
J. Nortier,
2010
.
Joshua C. Denny,
Jing Cui,
Elaine R. Mardis,
2014,
PloS one.
P. Neven,
H. Guchelaar,
S. Böhringer,
2019,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
H. Guchelaar,
R. Koopmans,
Lous J A E Doude van Troostwijk,
2003,
Fundamental & clinical pharmacology.
W. Assendelft,
H. Guchelaar,
J. Swen,
2010,
Pharmacogenomics.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2021,
Scientific Reports.
H. Guchelaar,
H. van der Sijs,
A. Vermes,
2000,
Chemotherapy.
H. Guchelaar,
G. Milano,
J. Ciccolini,
2021,
Cancer Chemotherapy and Pharmacology.
M. Neumaier,
H. Guchelaar,
R. V. van Schaik,
2019,
Clinica chimica acta; international journal of clinical chemistry.
J. Schellens,
H. Guchelaar,
R. Mathijssen,
2019,
The Lancet. Oncology.
H. Guchelaar,
H. Gelderblom,
J. Swen,
2017,
Journal of Gastrointestinal Cancer.
H. Guchelaar,
F. Locatelli,
F. Smiers,
2017,
British journal of haematology.
H. Guchelaar,
J. Swen,
M. T. ten Brink,
2014,
Drug discovery today.
Henk-Jan Guchelaar,
Jesse J Swen,
J. Schellens,
2016,
European journal of cancer.
H. Guchelaar,
D. Struijk,
R. Krediet,
2003,
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
T. Egberts,
H. Guchelaar,
K. Movig,
2011
.
H. Guchelaar,
A. Verbon,
J. S. Toraño,
1999,
Journal of chromatography. B, Biomedical sciences and applications.
H. Putter,
A. Egberts,
H. Guchelaar,
2009,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
H. Putter,
R. Paridaens,
C. Seynaeve,
2012,
Annals of oncology : official journal of the European Society for Medical Oncology.
H. Putter,
R. Paridaens,
C. Seynaeve,
2012
.
H. Guchelaar,
Y. Y. Liu,
L. J. van Troostwijk,
2001,
Biomedical chromatography : BMC.
T. van der Poll,
P. Speelman,
H. Guchelaar,
2000,
Antimicrobial Agents and Chemotherapy.
T. Egberts,
H. Guchelaar,
K. Movig,
2011,
European Journal of Clinical Pharmacology.
H. Guchelaar,
G. Toffoli,
R. Roncato,
2017,
Current pharmaceutical biotechnology.
H. Guchelaar,
Kirsten J.M. Schimmel,
S. D. de Wilde,
2018,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
H. Guchelaar,
J. Swen,
Xiaoyan Liu,
2017,
Pharmacogenomics.
C. Seynaeve,
J. Nortier,
H. Guchelaar,
2010
.
P. Neven,
D. Lambrechts,
R. Paridaens,
2016
.
Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge
Gustavo Stolovitzky,
Henk-Jan Guchelaar,
Larry W. Moreland,
2013,
Nature Genetics.
H. Guchelaar,
J. Falkenburg,
K. Schimmel,
2007,
Leukemia research.
Anyue Yin,
Dirk Jan A R Moes,
Johan G C van Hasselt,
2019,
CPT: pharmacometrics & systems pharmacology.
A. Nozari,
H. Guchelaar,
M. V. van Noorden,
2015,
Pharmacogenomics.
C. Cusin,
A. Nozari,
H. Guchelaar,
2016,
Anesthesia and analgesia.
M. Simoons,
J. Jukema,
J. Verschuren,
2011
.
H. Guchelaar,
Henk‐Jan Guchelaar,
Mirjam K. Rommers,
2007,
Pharmacoepidemiology and drug safety.
H. Guchelaar,
P. Merkus,
J. Sastre Toraño,
2000,
Biomedical chromatography : BMC.
C. Allaart,
H. Guchelaar,
T. Huizinga,
2010,
Pharmacogenomics.
J. Kremer,
N. Penrod,
H. Guchelaar,
2009,
Pharmacogenetics and genomics.
Y. Goekoop-Ruiterman,
J. D. de Vries-Bouwstra,
C. Allaart,
2007,
Pharmacogenomics.
J. D. de Vries-Bouwstra,
C. Allaart,
H. Guchelaar,
2006,
Arthritis and rheumatism.
Henk-Jan Guchelaar,
Barbara Franke,
Hans Scheffer,
2015,
Gastroenterology.
H. Guchelaar,
T. Huizinga,
J. Wesoły,
2006,
Current rheumatology reports.
H. Guchelaar,
J Dankert,
A Vermes,
2000,
The Journal of antimicrobial chemotherapy.
H. Guchelaar,
E. Kuijper,
A. Vermes,
2003,
Chemotherapy.
H. Guchelaar,
R. Mathôt,
A. Vermes,
2000,
Therapeutic drug monitoring.
H. Guchelaar,
A. Vermes,
J. Dankert,
2000,
Chemotherapy.
A. V. van Kuilenburg,
H. Guchelaar,
A. Vermes,
2002,
Fundamental & clinical pharmacology.
H. Guchelaar,
J. S. Toraño,
A. Vermes,
2001,
Biomedical chromatography : BMC.
H. Guchelaar,
R. Koopmans,
P. Kager,
2004,
Antimicrobial Agents and Chemotherapy.
Henk-Jan Guchelaar,
C. V. van Noorden,
D. Richel,
2004,
Cancer treatment reviews.
H. Guchelaar,
N. Mulder,
E. de Vries,
1992,
Clinical oncology (Royal College of Radiologists (Great Britain)).
H. Guchelaar,
H. van der Sijs,
A. Vermes,
1999,
Pharmacy World and Science.
H. Guchelaar,
H. Gelderblom,
N. V. van Erp,
2009,
Cancer treatment reviews.
H. Guchelaar,
S. Böhringer,
Kirsten J.M. Schimmel,
2018,
Scientific Reports.
H. Guchelaar,
K. Movig,
J. V. Vugt,
2010,
Neurology.
P. V. D. van der Boog,
J. D. de Fijter,
H. Guchelaar,
2018,
British journal of clinical pharmacology.
H. Guchelaar,
H. Gelderblom,
K. Schimmel,
2007
.
L. H. van den Berg,
P. V. van Vught,
H. Guchelaar,
2008,
Biopharmaceutics & drug disposition.
H. Guchelaar,
A. Vermes,
J. Meerwaldt,
1997,
Supportive Care in Cancer.
A. V. van Kuilenburg,
H. van Lenthe,
H. Guchelaar,
2008,
Biomedical chromatography : BMC.
H. Guchelaar,
K. Schimmel,
A. Verschuur,
2007
.
H. Guchelaar,
J. Koppe,
G. W. Ten Tusscher,
1999,
Biomedical chromatography : BMC.
H. Guchelaar,
H. Gelderblom,
H Gelderblom,
2010,
Current pharmaceutical design.
D. Richel,
H. Guchelaar,
H. Guchelaar,
1994,
Annals of Hematology.
Magnus Rattray,
Thomas Lengauer,
Haralampos Karanikas,
2016,
Genome Medicine.
H. Guchelaar,
T. van der Straaten,
2013,
Methods in molecular biology.
C. Punt,
H. Guchelaar,
S. Böhringer,
2015,
PloS one.
H. Guchelaar,
H. Gelderblom,
H. Morreau,
2011,
The oncologist.
M. Coenen,
H. Guchelaar,
D. M. T. te Loo,
2016,
Drug discovery today.
H. Guchelaar,
J. Swen,
J. J. Swen,
2013,
Clinical Pharmacokinetics.
H. Guchelaar,
S. Böhringer,
Kirsten J.M. Schimmel,
2019,
Cancer journal.
C. Punt,
H. Guchelaar,
J. Pander,
2010
.
H. Guchelaar,
H. Gelderblom,
M. Slingerland,
2014,
Anti-cancer drugs.
H. Guchelaar,
H. Gelderblom,
L. Krens,
2010,
Drug discovery today.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2014,
Mutation research.
H. Guchelaar,
H. Gelderblom,
J. Pander,
2007,
Drug discovery today.
H. Guchelaar,
S. Böhringer,
Kirsten J.M. Schimmel,
2018,
Scientific Reports.
L. Kiemeney,
K. Stefánsson,
G. Másson,
2017,
Urologic oncology.
M. Coenen,
H. Guchelaar,
M. Hakobjan,
2016,
Pharmacogenetics and genomics.
A. González-Neira,
M. Coenen,
H. Guchelaar,
2014,
PloS one.
H. Guchelaar,
H. Gelderblom,
J. den Hartigh,
2015,
Drug discovery today.
Henk-Jan Guchelaar,
H. Guchelaar,
H. Gelderblom,
2008,
Cancer treatment reviews.
H. Guchelaar,
H. Gelderblom,
R. Mathijssen,
2010,
Investigational New Drugs.
H. Guchelaar,
H. Elzevier,
M. Teichert,
2019,
Drug discovery today.
M. Relling,
M. Whirl‐Carrillo,
K. Sangkuhl,
2019,
Clinical and translational science.
H. Guchelaar,
H. Gelderblom,
A. Modak,
2013,
Clinical Pharmacokinetics.
A. Dahan,
E. Olofsen,
A. Nozari,
2016
.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2013,
Pharmacogenetics and genomics.
M. Coenen,
H. Guchelaar,
T. van der Straaten,
2015,
The Journal of molecular diagnostics : JMD.
R. Vossen,
S. Anvar,
P. Neven,
2021,
Science Translational Medicine.
M O Karlsson,
R M Turner,
C H van der Wouden,
2017,
Clinical pharmacology and therapeutics.
H. Guchelaar,
T. van der Straaten,
R. Baak-Pablo,
2010,
The Journal of molecular diagnostics : JMD.
S. Sleijfer,
H. Guchelaar,
H. Gelderblom,
2017,
The Pharmacogenomics Journal.
B. Rini,
H. Guchelaar,
H. Gelderblom,
2015,
European urology.
H. Guchelaar,
J. Haanen,
H. Gelderblom,
2010,
British Journal of Cancer.
H. Guchelaar,
J. Haanen,
H. Gelderblom,
2009,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
B. Ploeger,
H. Guchelaar,
H. Gelderblom,
2009
.
H. Guchelaar,
M. Koopman,
Kirsten J.M. Schimmel,
2017,
Clinical Pharmacokinetics.
H. Morreau,
H. Guchelaar,
T. van Wezel,
2016,
The Journal of clinical endocrinology and metabolism.
H. Guchelaar,
J. J. Swen,
P. C. Bank,
2014,
Expert review of molecular diagnostics.
P. V. D. van der Boog,
J. D. de Fijter,
H. Guchelaar,
2021,
Clinical Pharmacokinetics.
H. Guchelaar,
R. Koopmans,
A. Vermes,
1997,
Cancer treatment reviews.
H. Brunner,
A. González-Neira,
M. Coenen,
2022,
Frontiers in Pharmacology.
A. Verbeek,
M. Coenen,
H. Guchelaar,
2017,
The Pharmacogenomics Journal.
A. Verbeek,
D. D. de Jong,
M. Coenen,
2017,
Inflammatory bowel diseases.
H. Guchelaar,
S. Böhringer,
J. Swen,
2013,
Pharmacogenetics and genomics.
H. Guchelaar,
R. R. Press,
J. den Hartigh,
2008,
Therapeutic drug monitoring.
Masa Umicevic Mirkov,
Annette Lee,
P. Gregersen,
2012,
Annals of the rheumatic diseases.
H. Guchelaar,
J. Swen,
T. van der Straaten,
2013,
Pharmacogenomics.
B. Franke,
D. D. de Jong,
M. Coenen,
2017,
Journal of Crohn's & colitis.
B. Franke,
A. Verbeek,
M. Coenen,
2017,
Alimentary pharmacology & therapeutics.
B. Franke,
A. Verbeek,
D. D. de Jong,
2019,
Journal of Crohn's & colitis.
Jing Cui,
Barbara E. Stranger,
Henk-Jan Guchelaar,
2013,
PLoS genetics.
C. Seynaeve,
C. V. D. van de Velde,
H. Guchelaar,
2021,
Scientific Reports.
B. Ploeger,
M. Danhof,
J. D. de Fijter,
2016,
British journal of clinical pharmacology.
C. V. D. van de Velde,
H. Guchelaar,
H. Gelderblom,
2009,
Clinical Cancer Research.
H. Guchelaar,
J. Haanen,
H. Gelderblom,
2010,
Clinical Cancer Research.
H. Guchelaar,
L. Mullenders,
T. Straaten,
2017
.
H. Guchelaar,
L. Mullenders,
T. Straaten,
2011
.
J. D. de Fijter,
H. Guchelaar,
D. Moes,
2015,
Drug discovery today.
H. Putter,
C. Seynaeve,
H. Guchelaar,
2014,
Breast Cancer Research and Treatment.
S. Sleijfer,
H. Guchelaar,
H. Gelderblom,
2019,
The Pharmacogenomics Journal.
J. Coebergh,
M. Louwman,
H. Guchelaar,
2010,
Cancer Epidemiology, Biomarkers & Prevention.
J. Coebergh,
M. Louwman,
H. Guchelaar,
2010
.
J. D. de Fijter,
H. Guchelaar,
C. V. van Herpen,
2018,
British journal of clinical pharmacology.
Munir Pirmohamed,
Emmanuelle Rial-Sebbag,
Mats O Karlsson,
2020,
Pharmacogenetics and genomics.
A. V. van Kuilenburg,
J. Schellens,
H. Guchelaar,
2018,
Genes.
C. Allaart,
H. Guchelaar,
W. M. Kooloos,
2009
.
H. Guchelaar,
M. Kester,
S. Kruithof,
2011,
Journal of immunotherapy.
Henk-Jan Guchelaar,
Jos H Beijnen,
J. Schellens,
2012,
The oncologist.
E. D. de Vries,
E. Vellenga,
H. Guchelaar,
1994,
Pharmaceutical Research.
T. Egberts,
H. Guchelaar,
M. Arbouw,
2007,
Pharmacogenomics.
J. Nortier,
H. Guchelaar,
H. Gelderblom,
2011,
International Journal of Clinical Pharmacy.
H. Guchelaar,
R. Willemze,
I. Jedema,
2010,
Cytotherapy.
H. Guchelaar,
M. Griffioen,
P. V. van Veelen,
2012,
Journal of immunotherapy.
Henk-Jan Guchelaar,
D. D. de Jong,
H. Guchelaar,
2007,
Drug discovery today.
L. Kiemeney,
B. Rini,
H. Guchelaar,
2018,
Clinical Cancer Research.
H. Guchelaar,
R. Willemze,
I. Jedema,
2009,
Journal of immunotherapy.
H. Guchelaar,
H. Gelderblom,
M. Mustofa,
2012,
The International journal of biological markers.
J. Schellens,
H. Guchelaar,
H. Gelderblom,
2015,
Pharmacogenomics.
J. Nortier,
H. Guchelaar,
H. Gelderblom,
2005,
Clinical Cancer Research.
Huizinga,
C. Allaart,
H. Guchelaar,
2009
.
Hong Xu,
Matthias Samwald,
Kathrin Blagec,
2018,
J. Am. Medical Informatics Assoc..
C. Reutelingsperger,
H. Guchelaar,
I. Vermes,
1998,
Cancer Chemotherapy and Pharmacology.
H. Guchelaar,
F. Locatelli,
J. Zwaveling,
2019,
British journal of clinical pharmacology.
H. Guchelaar,
R. Egeler,
J. den Hartigh,
2006,
Anti-cancer drugs.
H. Guchelaar,
J. Swen,
R. Baak-Pablo,
2013,
Clinical pharmacology and therapeutics.
H. J. Woerdenbag,
H. Guchelaar,
M. Levi,
1998,
Pharmacy World and Science.
H. Guchelaar,
R. Koopmans,
Lous J A E Doude van Troostwijk,
2003,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
H. Guchelaar,
H. Gelderblom,
T. Links,
2016,
Cancer Chemotherapy and Pharmacology.
H. Guchelaar,
J. Swen,
Lisanne E N Manson,
2020,
Frontiers in Pharmacology.
D. Hommes,
J. Romijn,
H. Guchelaar,
2009,
The Journal of clinical endocrinology and metabolism.
J. Stingl,
H. Guchelaar,
G. Patrinos,
2017,
European Journal of Clinical Pharmacology.
H. Guchelaar,
J. Swen,
P. Bank,
2019,
European Journal of Human Genetics.
Henk-Jan Guchelaar,
Jesse J Swen,
H. Guchelaar,
2017,
Pharmacogenomics.
P. Hartvig,
H. Guchelaar,
V. Tjan-Heijnen,
2010
.
H. Guchelaar,
N. Mulder,
J. Oosterhuis,
1992,
Journal of pharmaceutical sciences.
Jesse J Swen,
Henk-Jan Guchelaar,
Maaike van der Lee,
2020,
Genes.
H. Guchelaar,
J. Swen,
A. Krętowski,
2021,
Frontiers in Pharmacology.
Hans Mulder,
H. Guchelaar,
J. Swen,
2018,
Clinical pharmacology and therapeutics.
H. Guchelaar,
S. D. de Wilde,
M. Zandvliet,
2016,
Molecular therapy. Methods & clinical development.
A. Zwinderman,
E. Sijbrands,
H. Guchelaar,
2009,
American journal of hypertension.
Henk-Jan Guchelaar,
Marije Slingerland,
H. Guchelaar,
2012,
Drug discovery today.
S. Sleijfer,
H. Guchelaar,
H. Gelderblom,
2017,
European journal of cancer.
H. Putter,
J. Jukema,
J. Verschuren,
2013,
International journal of cardiology.
C. Allaart,
S. le Cessie,
H. Guchelaar,
2007,
Arthritis and rheumatism.
H. Guchelaar,
Jos M. van den Broek,
M. V. van Beusekom,
2017,
Patient education and counseling.
H. Guchelaar,
O. Schouten,
L. Chandi,
1999
.
H. Guchelaar,
Jos M. van den Broek,
M. V. van Beusekom,
2016,
International Journal of Clinical Pharmacy.
S. Anvar,
H. Guchelaar,
C. Ruivenkamp,
2019,
Clinical pharmacology and therapeutics.
C. Punt,
H. Guchelaar,
H. Gelderblom,
2018,
PloS one.
H. Morreau,
H. Guchelaar,
T. van Wezel,
2015,
Investigational New Drugs.
B. Rini,
H. Guchelaar,
S. Böhringer,
2017,
Pharmacogenetics and genomics.
H. Guchelaar,
T. van der Straaten,
S. W. Lam,
2016,
British Journal of Cancer.
H. Guchelaar,
H. Gelderblom,
V. Dezentjé,
2008
.
M. Coenen,
H. Guchelaar,
H. Schreuder,
2015,
Clinical Cancer Research.
J. Romijn,
H. Guchelaar,
T. van der Straaten,
2008,
The Journal of clinical endocrinology and metabolism.
Jing Cui,
Philip L. De Jager,
Barbara E. Stranger,
2013,
PLoS genetics.
H. Guchelaar,
J. Zwaveling,
M. D. de Boer,
2021,
British journal of clinical pharmacology.
H. Guchelaar,
H. Gelderblom,
M. Deenen,
2020,
European journal of cancer.
Hein Putter,
Henk-Jan Guchelaar,
H. Putter,
2010,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
J. Beijnen,
H. Guchelaar,
H. Gelderblom,
2020,
Clinical pharmacology and therapeutics.
A. V. van Kuilenburg,
J. Maring,
C. Punt,
2016,
British journal of clinical pharmacology.
Judith A M Wessels,
Henk-Jan Guchelaar,
Pilar Barrera,
2012,
Pharmacogenomics.
J. Blay,
J. Verweij,
M. Glabbeke,
2009
.
J. Blay,
M. van Glabbeke,
J. Verweij,
2008,
Clinical Cancer Research.
H. Guchelaar,
R. Wolterbeek,
Jos M. van den Broek,
2015,
Patient education and counseling.
H. Guchelaar,
T. van Wezel,
H. Gelderblom,
2015,
Anti-cancer drugs.
C. Punt,
J. Schellens,
J. Beijnen,
2011,
Clinical Cancer Research.
M. Coenen,
H. Guchelaar,
S. Vermeulen,
2020,
Frontiers in Pharmacology.
H. Guchelaar,
J. Swen,
C. Dávila-Fajardo,
2013,
Pharmacogenomics.
M. Pirmohamed,
A. Cambon-Thomsen,
M. Ingelman-Sundberg,
2017,
Clinical pharmacology and therapy.
J. Maring,
H. Guchelaar,
H. Gelderblom,
2013,
The Pharmacogenomics Journal.
A. V. van Kuilenburg,
J. Maring,
H. Guchelaar,
2011,
Cancer Chemotherapy and Pharmacology.
C. Allaart,
H. Guchelaar,
J. Swen,
2019,
The Pharmacogenomics Journal.
H. Guchelaar,
T. Huizinga,
L. Padyukov,
2009
.
H. Guchelaar,
H. Gelderblom,
H. Verheul,
2015,
Journal of clinical pharmacology.
J. D. de Fijter,
H. Guchelaar,
R. R. Press,
2010,
Therapeutic drug monitoring.
H. Guchelaar,
H. Gelderblom,
J. Schellens,
2014,
Clinical pharmacology and therapeutics.
C. Punt,
H. Guchelaar,
J. de Ridder,
2020,
Bioinformatics.
R. Herings,
H. Guchelaar,
T. Nijsten,
2013,
European Journal of Clinical Pharmacology.
H. Rosing,
J. Beijnen,
H. Guchelaar,
2020,
Biomedical chromatography : BMC.
C. Allaart,
H. Guchelaar,
T. Huizinga,
2017,
Pharmacogenomics.
C. A. Albers,
M. A. van de Laar,
H. Brunner,
2014,
Annals of the rheumatic diseases.
H. Guchelaar,
T. Huizinga,
W. M. Kooloos,
2009
.
H. Guchelaar,
S. Böhringer,
Kirsten J.M. Schimmel,
2019,
Scientific Reports.
H. Guchelaar,
R. V. van Schaik,
J. Swen,
2021,
European Journal of Human Genetics.
Mirjam K. Rommers,
Juliëtte Zwaveling,
Henk-Jan Guchelaar,
2013,
Artif. Intell. Medicine.
Jan Pander,
Judith A M Wessels,
Ron H J Mathijssen,
2010,
Pharmacogenomics.
H. Putter,
A. Egberts,
H. Guchelaar,
2009,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
R. Herings,
H. Guchelaar,
T. Nijsten,
2009,
Cancer epidemiology.
H. Putter,
P. Neven,
H. Guchelaar,
2011,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
H. Guchelaar,
K. Weide,
H. Mirzakhani,
2016
.
H. Guchelaar,
2018,
European Journal of Human Genetics.
H. Guchelaar,
T. van der Straaten,
D. Kweekel,
2006,
The Journal of molecular diagnostics : JMD.
H. Guchelaar,
O. Ackaert,
J. Hartigh,
2014
.
Henk-Jan Guchelaar,
Jesse J Swen,
H. Guchelaar,
2016,
Pharmacogenomics.
H. Guchelaar,
H. Gelderblom,
J. den Hartigh,
2012,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
H. Guchelaar,
P. Vermeersch,
I. Spriet,
2021,
Mycoses.
H. Guchelaar,
H. Gelderblom,
J. Hartigh,
2013,
Cancer Chemotherapy and Pharmacology.
H. Guchelaar,
J. Swen,
P. Bank,
2018,
Pharmacogenomics.
H. Guchelaar,
A. Vermes,
J. Dankert,
2000,
The Journal of antimicrobial chemotherapy.
H. Guchelaar,
H. van der Sijs,
2002,
The Annals of pharmacotherapy.
C. Punt,
H. Guchelaar,
J. Swen,
2015,
Pharmacogenetics and genomics.
W. Assendelft,
M. Bouvy,
H. Guchelaar,
2011,
European Journal of Clinical Pharmacology.
Henk-Jan Guchelaar,
Mirjam K. Rommers,
Irene M. Teepe-Twiss,
2011,
Drug safety.
B. Rini,
H. Guchelaar,
H. Gelderblom,
2015,
European Journal of Clinical Pharmacology.
H. Guchelaar,
M. D. Kalmeijer,
M. Jansen,
2004,
Pharmacy World and Science.
C. Punt,
J. Schellens,
J. Beijnen,
2011,
Clinical Cancer Research.
C. Allaart,
H. Guchelaar,
S. Böhringer,
2018,
Pharmacogenomics.
H. Guchelaar,
H. Gelderblom,
J. Hartigh,
2009
.
A. V. van Kuilenburg,
D. Richel,
L. Zoetekouw,
2008,
Nucleosides, nucleotides & nucleic acids.
H. Guchelaar,
M. V. van Noorden,
J. Swen,
2015,
Pharmacogenetics and genomics.
E. D. de Vries,
H. Guchelaar,
N. Mulder,
1993,
Anti-Cancer Drugs.
K. Venkatakrishnan,
B. Rini,
H. Guchelaar,
2016,
Clinical pharmacology and therapy.
H. Guchelaar,
J. Swen,
T. van der Straaten,
2012,
Clinical chemistry and laboratory medicine.
H. Guchelaar,
H. Gelderblom,
A. Sparreboom,
2013
.
H. Guchelaar,
J. Haanen,
H. Gelderblom,
2010
.
S. Sleijfer,
H. Guchelaar,
H. Gelderblom,
2019,
The Pharmacogenomics Journal.
J. Schellens,
H. Guchelaar,
H. Gelderblom,
2016,
European journal of cancer.
H. Guchelaar,
J. Swen,
C. H. van der Wouden,
2022,
Clinics in laboratory medicine.
B. Franke,
A. Verbeek,
W. Newman,
2015,
Gastroenterology.
H. Guchelaar,
H. Gelderblom,
V. Dezentjé,
2009,
Clinical Cancer Research.
A. Nozari,
H. Guchelaar,
M. V. van Noorden,
2015,
Pharmacogenomics.
H. Guchelaar,
C. L. Kirkdale,
T. Thornley,
2021,
British journal of clinical pharmacology.
H. Guchelaar,
Kirsten J.M. Schimmel,
P. L. Le Brun,
2018,
Pharmacoepidemiology and drug safety.
H. Guchelaar,
O. Ackaert,
F. Smiers,
2014,
Therapeutic drug monitoring.
J. Blay,
J. Verweij,
H. Guchelaar,
2008,
Clinical Cancer Research.
H. Rosing,
J. Beijnen,
H. Guchelaar,
2013,
Clinical therapeutics.
J. Schellens,
H. Guchelaar,
H. Gelderblom,
2007,
Cancer Chemotherapy and Pharmacology.
H. Putter,
J. Nortier,
H. Guchelaar,
2011,
Japanese journal of clinical oncology.
H. Guchelaar,
N. Klazinga,
P. Wierenga,
2009,
Drug safety.
H. Guchelaar,
J. Haanen,
H. Gelderblom,
2010,
Clinical Cancer Research.
W. Assendelft,
E. D. de Vries,
H. Guchelaar,
2007,
PLoS medicine.